News

  Clinical testing not only greatly improves the level of medical care at every stage, from diagnosis through treatment, by making possible the early detection of a variety of diseases, but also broadly contributes to the advance of medicine.

  In order to create further advances in clinical testing, Sysmex funded the establishment of the “Assessment of Clinical Testing (Sysmex)” course at Kobe University in October 2004, marking the commencement of research into the assessment of clinical testing based on scientific evidence.

  Work in this course has consisted of research into the development, demonstration and evaluation of new clinical testing technologies, including the research and study of autoimmune diseases such as connective tissue disease and rheumatism. A close network among the Kobe Institute of Biomedical Research and Innovation, nearby flagship hospitals, and Sysmex will collaborate on this course continuously for three years. This will lead to advances in the development and verification of the utility of new clinical testing methods, bringing about the realization of personalized medicine, which is one of the challenges of 21^st century medicine. In addition to bringing about accuracy in diagnoses, the achievements of this course also contribute to the establishment of methodologies that can provide patients with efficient treatment with low side-effects, so we expect it to make significant contributions to society.

  Sysmex is committed to continuing our contributions to medical advancement through support for local universities and other community contributions.